Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T13:29:54.960Z Has data issue: false hasContentIssue false

Putting contract research organisations on the radar

Published online by Cambridge University Press:  02 January 2018

Mariëtte van Huijstee
Affiliation:
SOMO (Centre for Research on Multinational Corporations), Amsterdam, The Netherlands, email m.vanhuijstee@somo.nl
Nuria Homedes
Affiliation:
University of Texas, School of Public Health, USA
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

There is a trend for pharmaceutical companies to contract third parties to conduct the clinical trials that are needed to test their drugs. This trend is referred to as outsourcing, and the companies that carry out the work are called contract research organisations. In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low-and middle-income countries. This trend is called offshoring. The combination of outsourcing and offshoring poses serious risks for the ethical treatment of participants in clinical trials.

Information

Type
Thematic papers
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2012
Submit a response

eLetters

No eLetters have been published for this article.